Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Facebook Inc    FB

FACEBOOK INC

(FB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Facebook Removes Trump's Post About Covid-19, Citing Misinformation Rules -- Update

10/06/2020 | 04:29pm EST

By Jeff Horwitz

Facebook Inc. said it took down a post by President Trump playing down the deadliness Covid-19 Tuesday because it contained misinformation about the dangers of the coronavirus.

The social-media giant said its decision Tuesday was based on its policy against users spreading information deemed both wrong and harmful. Facebook said it makes determinations based on guidance from public-health authorities including the U.S. Centers for Disease Control and Prevention and the World Health Organization.

Mr. Trump's statement Tuesday that the seasonal flu is more dangerous for most people than the coronavirus is widely considered false by medical professionals. The disease already has killed more than 210,000 Americans, and the death rate per person infected has been far higher than historical rates for the seasonal flu, according to infectious disease experts.

"We remove incorrect information about the severity of Covid-19, and have now removed this post," said Facebook spokesman Andy Stone.

With its decision, the social network has moved to censor the president just weeks before Election Day. While Facebook Chief Executive Mark Zuckerberg has said the company doesn't wish to police political speech, Facebook has previously removed posts containing what it defines as coronavirus-related falsehoods. In March, Facebook removed content from Brazilian President Jair Bolsonaro promoting the drug hydroxychloroquine as effective at treating the virus in all cases. U.S. regulators later warned against such use of the antimalarial, which was widely touted by Mr. Trump, citing a lack of evidence for its effectiveness.

"In this instance, they've really made their policy clear and applied it to another world leader," said Kate Klonick, an assistant professor at St. John's University School of Law who has studied Facebook's moderation policies, referring to the platform's removal of Mr. Trump's post. "They can't make a special America exception to this."

Twitter Inc. also took action Tuesday in response to the president's similar claim on its own platform. Instead of removing the post, the company appended a notice that his tweet violated its rules on spreading harmful information related to the virus but that "it may be in the public's interest for the Tweet to remain accessible."

The company has said it prefers that approach so Twitter users can respond publicly to their leaders and hold them accountable. Twitter said it also limited the distribution of Mr. Trump's tweet across its platform.

The tech companies' actions come a day after the president returned an unusually quiet White House following three days of hospitalization for Covid-19 as his administration continues to grapple with rising coronavirus infections among staffers. The Joint Chiefs of Staff, the senior military advisers to the president, have gone into quarantine after a possible exposure earlier this week, defense officials said Tuesday.

In an apparent response to the two social-media companies' treatment of his posts, Mr. Trump posted on both platforms "REPEAL SECTION 230!!!," referring to the law that gives internet platforms the right to moderate content without taking on the legal responsibilities of publishers. A Trump campaign spokeswoman condemned the removal, saying that "attempts to silence the President will not stop him leading on this issue."

Both Republicans and Democrats have raised the prospect of changing the law in response to concerns that social-media companies are either restricting speech too heavily or failing to address routine abuses on their platforms. Social-media platforms have pushed back against those calls, saying that the law is foundational to free and open discourse online.

Medical professionals, meanwhile, have focused on trying to combat coronavirus misinformation on social media. A growing group of scientists and public-health officials have become increasingly active on Facebook and Twitter, among other platforms, and drawn large audiences during the pandemic.

Write to Jeff Horwitz at Jeff.Horwitz@wsj.com

(END) Dow Jones Newswires

10-06-20 1628ET

Stocks mentioned in the article
ChangeLast1st jan.
EURO / BRAZILIAN REAL (EUR/BRL) -0.11% 6.3014 Delayed Quote.41.18%
FACEBOOK INC 3.46% 286.55 Delayed Quote.39.61%
TWITTER 0.34% 46.67 Delayed Quote.45.62%
All news about FACEBOOK INC
04:49aStocks rest after vaccine progress, dollar stuck at two-and-a-half-year low
RE
04:45aGlobal stocks rest after vaccine progress, dollar stuck at 2-1/2 year low
RE
01:30aFACEBOOK : Signs of dissent within Thai military as protests grow
RE
01:18aSoftBank winding down derivatives after investor backlash - Bloomberg News
RE
12:38aAsian shares bounce on hopes for U.S. stimulus, vaccine
RE
12/01Trump vows defense bill veto unless internet liability shield scrapped
RE
12/01FACEBOOK : From hate speech to nudity, Facebook's oversight board picks its firs..
RE
12/01GLOBAL MARKETS LIVE: Bank of America, Pfizer, Tesla…
12/01Facebook-backed digital coin Libra renamed Diem in quest for approval
RE
12/01FACEBOOK : Oversight Board Selects Case on Armenians in Azerbaijan
PU
More news
Financials (USD)
Sales 2020 83 587 M - -
Net income 2020 26 870 M - -
Net cash 2020 63 906 M - -
P/E ratio 2020 30,7x
Yield 2020 -
Capitalization 816 B 816 B -
EV / Sales 2020 9,00x
EV / Sales 2021 7,06x
Nbr of Employees 56 653
Free-Float 83,8%
Chart FACEBOOK INC
Duration : Period :
Facebook Inc Technical Analysis Chart | FB | US30303M1027 | MarketScreener
Technical analysis trends FACEBOOK INC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 51
Average target price 315,73 $
Last Close Price 286,55 $
Spread / Highest target 30,9%
Spread / Average Target 10,2%
Spread / Lowest Target -58,1%
EPS Revisions
Managers
NameTitle
Mark Elliot Zuckerberg Chairman & Chief Executive Officer
Sheryl Kara Sandberg Chief Operating Officer & Director
David M. Wehner Chief Financial Officer
Michael Todd Schroepfer Chief Technology Officer
Atish Banerjea Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
FACEBOOK INC39.61%816 178
MATCH GROUP, INC.74.53%38 118
TWITTER45.62%37 026
LINE CORPORATION0.56%12 493
SINA CORPORATION8.44%2 586
NEW WORK SE-10.10%1 778